medigraphic.com
ISSN 2992-779X (Electronic)
ISSN 2007-6452 (Print)

2022, Number 3

<< Back Next >>

Investigación en Discapacidad 2022; 8 (3)

The role of physical activity on depression in patients with Parkinson´s disease

Cortés H, Contreras-Tovar PS, Rojas-Márquez M, Leyva-García N, Giménez-Carrillo R, Florán B, Leyva-Gómez G

Language: Spanish
References: 37
Page: 115-123
PDF size: 270.06 Kb.


ABSTRACT

Depression frequently occurs in patients with Parkinson's disease (PD), affecting approximately 50%. Currently, the treatment of this disorder is based on the administration of selective serotonin reuptake inhibitors. However, these drugs can often lead to numerous side effects that impair patients' quality of life. Therefore, it is necessary to identify other effective and safe treatments. There is evidence that practicing physical exercises reduces inflammation, improves cerebral blood flow, increases the production of neurotrophic factors, and increases the volume of brain areas related to memory and cognitive function, improving mood and some mental aspects. Therefore, physical activity can counteract brain alterations associated with neurodegenerative disorders and depression. In this regard, some studies have been conducted to determine whether such exercises can improve mental health in people with PD. In particular, some research groups have proposed resistance training, aerobic exercises, yoga, dance, virtual reality-based approaches, and exergames to reduce depression levels in these patients. Therefore, there is increasing evidence supporting the usefulness of performing physical exercises to treat depression in these patients. This article aims to highlight the therapeutic potential of performing physical activity in managing depression in patients with PD.


REFERENCES

  1. Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016; 15 (12): 1257-1272.

  2. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson's disease: a review of the evidence. Eur J Epidemiol. 2011; 26 (1): 51-58.

  3. Schapira AH V. Neurobiology and treatment of Parkinson's disease. Trends Pharmacol Sci. 2009; 30 (1): 41-47.

  4. Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Prim. 2017; 3: 1-21.

  5. Reijnders JSAM, Ehrt U, Weber WEJ, Aarsland D, Leentjens AFG. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008; 23 (2): 183-189.

  6. Pachana NA, Egan SJ, Laidlaw K, Dissanayaka N, Byrne GJ, Brockman S, et al. Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease. Mov Disord. 2013; 28 (14): 1930-1934.

  7. Ryan M, Eatmon C V, Slevin JT. Drug treatment strategies for depression in Parkinson disease. Expert Opin Pharmacother. 2019; 20 (11): 1351-1363.

  8. Skapinakis P, Bakola E, Salanti G, Lewis G, Kyritsis AP, Mavreas V. Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. BMC Neurol. 2010; 10: 49.

  9. de Lima TA, Ferreira-Moraes R, Alves WMG da C, Alves TGG, Pimentel CP, Sousa EC, et al. Resistance training reduces depressive symptoms in elderly people with Parkinson disease: A controlled randomized study. Scand J Med Sci Sports. 2019; 29 (12): 1957-1967.

  10. Wu PL, Lee M, Huang TT. Effectiveness of physical activity on patients with depression and Parkinson's disease: A systematic review. PLoS One. 2017; 12 (7): e0181515.

  11. Wu PL, Lee M, Wu SL, Ho HH, Chang MH, Lin HS, et al. Effects of home-based exercise on motor, non-motor symptoms and health-related quality of life in Parkinson's disease patients: A randomized controlled trial. Jpn J Nurs Sci. 2021; e12418.

  12. Picelli A, Varalta V, Melotti C, Zatezalo V, Fonte C, Amato S, et al. Effects of treadmill training on cognitive and motor features of patients with mild to moderate Parkinson's disease: a pilot, single-blind, randomized controlled trial. Funct Neurol. 2016; 31 (1): 25-31.

  13. Ban M, Yue X, Dou P, Zhang P. The Effects of Yoga on Patients with Parkinson's Disease: A Meta-Analysis of Randomized Controlled Trials. Witt K, editor. Behav Neurol. 2021; 2021: 5582488.

  14. Wang L li, Sun C jie, Wang Y, Zhan T ting, Yuan J, Niu CY, et al. Effects of dance therapy on non-motor symptoms in patients with Parkinson's disease: a systematic review and meta-analysis. Aging Clin Exp Res. 2022; 34 (6): 1201-1208.

  15. Song R, Grabowska W, Park M, Osypiuk K, Vergara-Diaz GP, Bonato P, et al. The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis. Parkinsonism Relat Disord. 2017; 41: 3-13.

  16. Dockx K, Bekkers EM, Van den Bergh V, Ginis P, Rochester L, Hausdorff JM, et al. Virtual reality for rehabilitation in Parkinson's disease. Cochrane database Syst Rev. 2016; 12 (12): CD010760.

  17. Marotta N, Demeco A, Indino A, de Scorpio G, Moggio L, Ammendolia A. Nintendo Wii(TM) versus Xbox Kinect(TM) for functional locomotion in people with Parkinson's disease: a systematic review and network meta-analysis. Disabil Rehabil. 2022; 44 (3): 331-336.

  18. Altmann LJP, Stegemöller E, Hazamy AA, Wilson JP, Bowers D, Okun MS, et al. Aerobic Exercise Improves Mood, Cognition, and Language Function in Parkinson's Disease: Results of a Controlled Study. J Int Neuropsychol Soc. 2016; 22 (9): 878-889.

  19. van der Kolk NM, de Vries NM, Penko AL, van der Vlugt M, Mulder AA, Post B, et al. A remotely supervised home-based aerobic exercise programme is feasible for patients with Parkinson's disease: results of a small randomised feasibility trial. J Neurol Neurosurg Psychiatry. 2018; 89 (9): 1003-1005.

  20. Schmitz-Hübsch T, Pyfer D, Kielwein K, Fimmers R, Klockgether T, Wüllner U. Qigong exercise for the symptoms of Parkinson's disease: A randomized, controlled pilot study. Mov Disord. 2006; 21 (4): 543-548.

  21. Lee HJ, Kim SY, Chae Y, Kim MY, Yin C, Jung WS, et al. Turo (Qi Dance) Program for Parkinson's Disease Patients: Randomized, Assessor Blind, Waiting-List Control, Partial Crossover Study. EXPLORE. 2018; 14 (3): 216-223.

  22. Sharma NK, Robbins K, Wagner K, Colgrove YM. A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson's disease. Int J Yoga. 2015; 8 (1): 74-79.

  23. Cheung C, Bhimani R, Wyman JF, Konczak J, Zhang L, Mishra U, et al. Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial. Pilot feasibility Stud. 2018; 4: 162.

  24. Borrione P, Tranchita E, Sansone P, Parisi A. Effects of physical activity in Parkinson's disease: A new tool for rehabilitation. World J Methodol. 2014; 4 (3): 133-143.

  25. Cugusi L, Solla P, Serpe R, Carzedda T, Piras L, Oggianu M, et al. Effects of a Nordic Walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease. NeuroRehabilitation. 2015; 37: 245-254.

  26. Hashimoto H, Takabatake S, Miyaguchi H, Nakanishi H, Naitou Y. Effects of dance on motor functions, cognitive functions, and mental symptoms of Parkinson's disease: a quasi-randomized pilot trial. Complement Ther Med. 2015; 23 (2): 210–9.

  27. Lee NY, Lee DK, Song HS. Effect of virtual reality dance exercise on the balance, activities of daily living, and depressive disorder status of Parkinson's disease patients. J Phys Ther Sci. 2015; 27 (1): 145-147.

  28. Solla P, Cugusi L, Bertoli M, Cereatti A, Della Croce U, Pani D, et al. Sardinian Folk Dance for Individuals with Parkinson's Disease: A Randomized Controlled Pilot Trial. J Altern Complement Med. 2019; 25 (3): 305-316.

  29. Tollár J, Nagy F, Hortobágyi T. Vastly Different Exercise Programs Similarly Improve Parkinsonian Symptoms: A Randomized Clinical Trial. Gerontology. 2019; 65 (2): 120-127.

  30. Agudelo LZ, Femenía T, Orhan F, Porsmyr-Palmertz M, Goiny M, Martinez-Redondo V, et al. Skeletal muscle PGC-1α1 modulates kynurenine metabolism and mediates resilience to stress-induced depression. Cell. 2014; 159 (1): 33-45.

  31. Aarsland D, Påhlhagen S, Ballard CG, Ehrt U, Svenningsson P. Depression in Parkinson disease--epidemiology, mechanisms and management. Nat Rev Neurol. 2011; 8 (1): 35-47.

  32. Berchtold NC, Kesslak JP, Cotman CW. Hippocampal brain-derived neurotrophic factor gene regulation by exercise and the medial septum. J Neurosci Res. 2002; 68 (5): 511-521.

  33. Schaeffer E, Roeben B, Granert O, Hanert A, Liepelt-Scarfone I, Leks E, et al. Effects of exergaming on hippocampal volume and brain-derived neurotrophic factor levels in Parkinson's disease. Eur J Neurol. 2022; 29 (2): 441-449.

  34. D'Ascola A, Bruschetta G, Zanghì G, Campo S, Medica P, Campana S, et al. Changes in plasma 5-HT levels and equine leukocyte SERT expression in response to treadmill exercise. Res Vet Sci. 2018; 118: 184-190.

  35. Basso JC, Suzuki WA. The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review. Brain Plast. 2017; 2: 127–52.

  36. Speelman AD, van de Warrenburg BP, van Nimwegen M, Petzinger GM, Munneke M, Bloem BR. How might physical activity benefit patients with Parkinson disease? Nat Rev Neurol. 2011; 7 (9): 528-534.

  37. Zoladz JA, Majerczak J, Zeligowska E, Mencel J, Jaskolski A, Jaskolska A, et al. Moderate-intensity interval training increases serum brain-derived neurotrophic factor level and decreases inflammation in Parkinson's disease patients. J Physiol Pharmacol an Off J Polish Physiol Soc. 2014; 65 (3): 441-448.




2020     |     www.medigraphic.com